Evidence map›Paper›PMID 36789126›Full record

ArticleFujita medical journal2023

Post-discharge clinical, laboratory and radiographic features of coronavirus disease 2019 (COVID-19) patients at university hospitals in Japan.

Toshiharu Sasaki, Yoko Toyama, Tomoya Horiguchi, Masaya Hibino, Sei-Ichiro Tsuzuki, Masamichi Hayashi, Yohei Doi, Mitsunaga Iwata, Kazuyoshi Imaizumi, Masato Inaba

Open access · greenAbstract read
In one paragraph

Article in Fujita medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Current Views About the Link between SARS-CoV-2 and the Liver: Friends or Foe?Endocrine, metabolic & immune disorders drug targets · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Toshiharu SasakiDepartment of Infectious Diseases, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Yoko ToyamaDepartment of Respiratory Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Tomoya HoriguchiDepartment of Respiratory Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Masaya HibinoDepartment of Emergency and General Internal Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Sei-Ichiro TsuzukiDepartment of Emergency and General Internal Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Masamichi HayashiDepartment of Respiratory Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Yohei DoiDepartment of Infectious Diseases, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Mitsunaga IwataDepartment of Emergency and General Internal Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Kazuyoshi ImaizumiDepartment of Respiratory Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Masato InabaDepartment of Infectious Diseases, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Fujita Health University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Coronavirus disease 2019 (COVID-19) has affected nearly half million people in Japan. However, information on the prolonged symptoms as well as laboratory and radiographic findings after hospital discharge remains limited. Methods: We retrospectively collected the symptoms, laboratory test results, and chest imaging results of COVID-19 patients at the time of the hospital admission and the ambulatory visits after discharge at two university hospitals between July and December 2020. Patients: A total of 126 COVID-19 patients, including of 88 with mild to moderate disease and 38 with severe to critical disease, were included. The time between symptom onset and the first outpatient visit was 46 days (Interquartile range, 39 to 55). Results: At the ambulatory visits, 36.5% of patients had at least one symptom. The most frequent symptom was shortness of breath (12.8%), followed by cough (11.1%), and fatigue (8.8%). Of 120 patients with post-discharge laboratory test results, 27 patients (22.5%) had abnormal alanine aminotransferase levels, and 35 patients (29.1%) had lymphocytopenia, including 24 and 27 mild and moderate patients. Of 122 patients with post-discharge chest computed tomography (CT) scans, 105 (83.3%) had abnormal findings. This abnormality was found in both mild to moderate and severe patients. Conclusions: Shortness of breath, abnormal liver function test results and chest CT images often persisted for at least one month after discharge, even when symptoms were mild or moderate during hospitalization.

Indexed as

Alanine aminotransferaseCohort studyComputed tomographyLong COVIDSARS-CoV-2

Identifiers

PMID36789126
PMCPMC9923454
OpenAlexW4320856854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.